Literature DB >> 4674079

Enhancement of hemagglutination inhibition by complement.

P W Reno, E M Hoffmann.   

Abstract

Experiments were conducted to determine the effect of specific antibody and complement on hemagglutination inhibition of influenza virus. It was found that early immunoglobulin M antibody to influenza virus inhibited the hemagglutinating capacity of the virus. When fresh guinea pig serum was added, the inhibiting capacity of the serum was elevated from four- to eightfold When guinea pig serum was treated with known complement inhibitors, it lost its capacity to enhance hemagglutination. The use of functionally purified complement components indicated that the first, second, and fourth components were necessary and sufficient for enhancement of hemagglutination inhibition by specific antibody to influenza virus.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4674079      PMCID： PMC419316          DOI： 10.1128/iai.6.6.945-951.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  17 in total

1.  Measurements of complement by agglutination of human erythrocytes reacting in immune-adherence.

Authors:  K NISHIOKA
Journal:  J Immunol       Date:  1963-01       Impact factor: 5.422

2.  Thermolability of specific haemagglutination inhibiting antibodies against FE influenza virus and their reactivation by the addition of fresh serum.

Authors:  B STYK; V RATHOVA; D BLASKOVIC
Journal:  Acta Virol       Date:  1958 Jul-Sep       Impact factor: 1.162

3.  STUDIES ON SERUM PROTEINS. I. IDENTIFICATION OF A SINGLE SERUM GLOBULIN BY IMMUNOLOGICAL MEANS. ITS DISTRIBUTION IN THE SERA OF NORMAL INDIVIDUALS AND OF PATIENTS WITH CIRRHOSIS OF THE LIVER AND WITH CHRONIC GLOMERULONEPHRITIS.

Authors:  F E Kendall
Journal:  J Clin Invest       Date:  1937-11       Impact factor: 14.808

4.  Neutralization of sensitized virus by purified components of complement.

Authors:  C A Daniels; T Borsos; H J Rapp; R Snyderman; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1970-03       Impact factor: 11.205

Review 5.  Chemistry and reaction mechanisms of complement.

Authors:  H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

6.  Isolation of 14C-labeled influenza virus from tissue culture, using Ecteola cellulose for final purification.

Authors:  P M Buckley; K S Pilcher
Journal:  Arch Gesamte Virusforsch       Date:  1967

7.  C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

8.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

9.  C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; I H LEPOW
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

10.  COMPONENTS OF GUINEA PIG COMPLEMENT. II. SEPARATION OF SERUM FRACTIONS ESSENTIAL FOR IMMUNE HEMOLYSIS.

Authors:  W D LINSCOTT; K NISHIOKA
Journal:  J Exp Med       Date:  1963-11-01       Impact factor: 14.307
View more
  5 in total

1.  Effect of heat-labile factors on the neutralization of vaccinia virus by human.

Authors:  K Takabayashi; K McIntosh
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

2.  Appearance of slow-reacting, complement-requiring hemagglutination-inhibiting antibody in swine infected with pseudorabies virus.

Authors:  Y Inaba; N Tetsu; H Toriyoshi; M Yukawa; K Yoshiki; T Hirahara; A Izumida
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement.

Authors:  A L Frank; J Puck; B J Hughes; T R Cate
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

4.  Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.

Authors:  Falko Schmeisser; Rachel Friedman; Joseph Besho; Vladimir Lugovtsev; Jackeline Soto; Wei Wang; Carol Weiss; Ollie Williams; Hang Xie; Zhiping Ye; Jerry P Weir
Journal:  Influenza Other Respir Viruses       Date:  2012-11-05       Impact factor: 4.380

5.  A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines.

Authors:  Falko Schmeisser; Anupama Vasudevan; Jackeline Soto; Arunima Kumar; Ollie Williams; Jerry P Weir
Journal:  Influenza Other Respir Viruses       Date:  2014-08-02       Impact factor: 4.380
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.